Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma

Background: Traditionally, the treatment options for unresectable locally advanced (UR-LA) and metastatic (UR-M) pancreatic ductal adenocarcinoma (PDAC) are palliative chemotherapy or chemoradiotherapy. The benefits of surgery for such patients remains unknown. The present study investigated clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagimoto, Hiroaki, Satoi, Sohei, Yamamoto, Tomohisa, Yamaki, So, Hirooka, Satoshi, Kotsuka, Masaya, Ryota, Hironori, Ishida, Mitsuaki, Matsui, Yoichi, Sekimoto, Mitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352934/
https://www.ncbi.nlm.nih.gov/pubmed/32486418
http://dx.doi.org/10.3390/cancers12061428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352934/
https://www.ncbi.nlm.nih.gov/pubmed/32486418
http://dx.doi.org/10.3390/cancers12061428

Ejemplares similares